Clinical Trial: 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590336) titled '68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma' on May 06.

Brief Summary: This is a prospective, single-center, single-arm, phase I/II study designed to evaluate (1) the safety, tolerability, and imaging characteristics of 68Ga-NYM207 (Phase A), and (2) the diagnostic performance of 68Ga-NYM207 in detecting hepatocellular carcinoma (HCC) (Phase B). This study will provide critical insights into the performance of 68Ga-NYM207 PET/CT as a non-invasive imaging tool for the detection of HCC.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Hepatocellular Carcinoma (HCC)

Intervention: DIAGNOSTIC_TEST: 68Ga-NYM...